top of page

Topic

2025 HCC Creator Weekend™

9 Podcasts on BackTable

Principles to Practice: An HCC Tumor Board
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 9  •  17 Jan 2025

Principles to Practice: An HCC Tumor Board

Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).

This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.

More on 2025 HCC Creator Weekend™

Loading recent podcasts…

Tumor Board

Tumor Board Episode #9

Jan 17, 2025

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia, Dr. Zach Berman

Principles to Practice: An HCC Tumor Board

Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited...

2,400+ listens

Tumor Board

Tumor Board Episode #7

Jan 17, 2025

with Dr. John Seal, Dr. Gabriel Schnickel, Dr. Siddharth Padia, Dr. Sabeen Dhand

Surgery for HCC: What’s Its Role Today?

Is surgery truly the "cure" for hepatocellular carcinoma (HCC), and when is it a viable option? In this episode, Dr....

1,700+ listens

Tumor Board

Tumor Board Episode #5

Jan 17, 2025

with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes, Dr. Lingling Du, Dr. Sabeen Dhand

Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do

Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to...

2,200+ listens

Tumor Board

Tumor Board Episode #3

Jan 17, 2025

with Dr. Lingling Du, Dr. Jonathan Mizrahi, Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Tyler Sandow

Combination Therapy & Clinical Trials for Advanced HCC: What They Really Mean

In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative...

3,800+ listens

Tumor Board

Tumor Board Episode #8

Jan 17, 2025

with Dr. Siddharth Padia, Dr. Kevin Burns, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy, Dr. Zach Berman

Getting Started in Interventional Oncology: Tips for Starting Your Career

Are you seeking to build your reputation and patient base within interventional oncology? In this episode, host Dr....

1,900+ listens

Tumor Board

Tumor Board Episode #6

Jan 17, 2025

with Dr. Heather Patton, Dr. John Seal, Dr. Steven Young, Dr. Zach Berman

Transplantation for HCC: Who, When & How?

The process of liver transplantation involves many complexities, and each patient's path to transplant is unique. To...

1,900+ listens

Tumor Board

Tumor Board Episode #4

Jan 17, 2025

with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand, Dr. Zach Berman, Dr. Tyler Sandow

Curative Intent Therapies for HCC: Today & Tomorrow

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation...

2,200+ listens

Tumor Board

Tumor Board Episode #2

Jan 17, 2025

with Dr. Siddharth Padia, Dr. Sabeen Dhand, Dr. Zach Berman, Dr. Kirema Garcia-Reyes, Dr. Tyler Sandow

How to Simplify Dosing: Understanding Y90 Dosimetry from Simple to Complex

Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after...

5,100+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page